The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Acadia's first-quarter earnings and revenues miss estimates despite 10% sales growth, driven by Nuplazid and Daybue demand.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Investors in Acadia Pharmaceuticals Inc (Symbol: ACAD) saw new options begin trading this week, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is ...

Shares of Acadia Pharmaceuticals ACAD lost 9.9% on Wednesday after the company announced a disappointing update from a late-stage study of its investigational candidate, intranasal carbetocin (ACP-101 ...

It has been about a month since the last earnings report for Acadia Pharmaceuticals (ACAD). Shares have added about 22.6% in that time frame, outperforming the S&P 500. But investors have to be ...